Difference between revisions of "Team:BGU Israel"

 
(3 intermediate revisions by one other user not shown)
Line 48: Line 48:
 
     <div id="Div1">
 
     <div id="Div1">
  
      <div id="wikicontent-container">
+
            <div id="wikicontent-container">
        <div id="wikicontent">
+
              <div id="wikicontent">
          <br />
+
                <br />
          <br />
+
                <br />
  
  
          <ul class="bxslider">
+
<ul class="bxslider">  
            <li>
+
                              <li><img src="https://static.igem.org/mediawiki/2015/2/26/BGU_home_slider_team1.jpg" /></li>
              <img src="https://static.igem.org/mediawiki/2015/2/26/BGU_home_slider_team1.jpg" />
+
                              <li><img src="https://static.igem.org/mediawiki/2015/a/a3/BGU_home_slider_team2.jpg" /></li>
            </li>
+
                              <li><img src="https://static.igem.org/mediawiki/2015/4/42/BGU_home_slider_team3.jpg" /></li>
            <li>
+
                              <li><img src="https://static.igem.org/mediawiki/2015/5/5c/BGU_home_slider_team4.jpg" /></li>
              <img src="https://static.igem.org/mediawiki/2015/a/a3/BGU_home_slider_team2.jpg" />
+
                              <li><img src="https://static.igem.org/mediawiki/2015/6/6a/BGU_home_slider_team5.jpg" /></li>
            </li>
+
                              <li><img src="https://static.igem.org/mediawiki/2015/b/b6/BGU_home_slider_team6.jpg" /></li>
            <li>
+
                          </ul>
              <img src="https://static.igem.org/mediawiki/2015/4/42/BGU_home_slider_team3.jpg" />
+
       
            </li>
+
               
            <li>
+
     
              <img src="https://static.igem.org/mediawiki/2015/5/5c/BGU_home_slider_team4.jpg" />
+
        <div style="height: 145px; margin: 5px 0px 5px;">
            </li>
+
            <li>
+
              <img src="https://static.igem.org/mediawiki/2015/6/6a/BGU_home_slider_team5.jpg" />
+
            </li>
+
            <li>
+
              <img src="https://static.igem.org/mediawiki/2015/b/b6/BGU_home_slider_team6.jpg" />
+
            </li>
+
          </ul>
+
 
+
 
+
 
+
          <div style="height: 145px; margin: 5px 0px 5px;">
+
 
             <table style="width: 100%; border-style: hidden;" >
 
             <table style="width: 100%; border-style: hidden;" >
              <tr style="border-style: hidden;">
+
                <tr style="border-style: hidden;">
                <td style="border-style: hidden;">
+
<td style="border-style: hidden;"><a href="https://2015.igem.org/Team:BGU_Israel/Achievements" ><div align="center"><img src="https://static.igem.org/mediawiki/2015/1/17/BGU_home_icon_trophy.png" alt=""></a></div></td>
                  <a href="https://2015.igem.org/Team:BGU_Israel/Achievements" >
+
                    <div align="center">
+
                      <img src="https://static.igem.org/mediawiki/2015/1/17/BGU_home_icon_trophy.png" alt="" />
+
                    </div>
+
                  </a>
+
                </td>
+
                <td style="border-style: hidden;">
+
                  <a href="https://2015.igem.org/Team:BGU_Israel/Description">
+
                    <div align="center">
+
                      <img src="https://static.igem.org/mediawiki/2015/3/3d/Bgu_project.png" alt="" />
+
                    </div>
+
                  </a>
+
  
                </td>
+
<td style="border-style: hidden;"><a href="https://2015.igem.org/Team:BGU_Israel/Description"><div align="center"><img src="https://static.igem.org/mediawiki/2015/3/3d/Bgu_project.png" alt=""></a></div></td>
  
                <td style="border-style: hidden;">
+
<td style="border-style: hidden;"><a href="https://2015.igem.org/Team:BGU_Israel/Design" ><div align="center"><img src="https://static.igem.org/mediawiki/2015/6/6b/Bgu_brush-pencil.png" alt=""></a></div></td>
                  <a href="https://2015.igem.org/Team:BGU_Israel/Design" >
+
                    <div align="center">
+
                      <img src="https://static.igem.org/mediawiki/2015/6/6b/Bgu_brush-pencil.png" alt="" />
+
                    </div>
+
                  </a>
+
  
                </td>
+
<td style="border-style: hidden;"><a href="https://2015.igem.org/Team:BGU_IsraelResults"><div align="center"><img src="https://static.igem.org/mediawiki/2015/b/b0/Bgu_brightness.png" alt=""></a></div></td>
 +
<!-- https://static.igem.org/mediawiki/2015/b/b9/BGU_home_icon_briefcase.png -->
  
                <td style="border-style: hidden;">
+
<td style="border-style: hidden;"><a href="https://2015.igem.org/Team:BGU_Israel/Practices" ><div align="center"><img src="https://static.igem.org/mediawiki/2015/8/89/BGU_Rgb.png" alt=""></a></div></td>
                  <a href="https://2015.igem.org/Team:BGU_IsraelResults">
+
                    <div align="center">
+
                      <img src="https://static.igem.org/mediawiki/2015/b/b0/Bgu_brightness.png" alt="" />
+
                    </div>
+
                  </a>
+
  
                </td>
 
                <!-- https://static.igem.org/mediawiki/2015/b/b9/BGU_home_icon_briefcase.png -->
 
  
                <td style="border-style: hidden;">
 
                  <a href="https://2015.igem.org/Team:BGU_Israel/Practices" >
 
                    <div align="center">
 
                      <img src="https://static.igem.org/mediawiki/2015/8/89/BGU_Rgb.png" alt="" />
 
                    </div>
 
                  </a>
 
  
                </td>
 
 
               </tr>
 
               </tr>
 
               <tr style="border-style: hidden;">
 
               <tr style="border-style: hidden;">
Line 130: Line 88:
 
                     <td style="text-align: left; border-style: hidden;"><div align="center">Results</div></td>
 
                     <td style="text-align: left; border-style: hidden;"><div align="center">Results</div></td>
 
                     <td style="text-align: left; border-style: hidden;"><div align="center">Practices and Polices</div></td>
 
                     <td style="text-align: left; border-style: hidden;"><div align="center">Practices and Polices</div></td>
              </tr>
+
                   
 +
                 
 +
          </tr>
 +
 
 
             </table>
 
             </table>
 
         </div>
 
         </div>
 
<br />
 
<br />
  
          <h2>
+
<h2> <span class="mw-headline" id="PhyscoFilter_.E2.80.93_Clean_different."> The Boomerang system: synthetic machine for cancer therapy </span></h2>
            <span class="mw-headline" id="PhyscoFilter_.E2.80.93_Clean_different."> The Boomerang system: synthetic machine for cancer therapy </span>
+
<p>Despite recent treatment advancements, cancer is still a major cause of mortality worldwide. One of the fundamental problems preventing the development of effective therapy is the difficulty to target cancer cells exclusively.  
          </h2>
+
  <br />In Boomerang, we're engineering a genetic device based on a simple concept of AND logic gate: the activation of our CRISPR/Cas9-based system is dependent on the existence of two cancer-specific promoters that control the expression of Cas9 and gRNA, and the combination of these two will occur only in cancer cells. CRISPR/Cas9 system allows several applications of Boomerang: 1) disruption of genes essential for cancer survival; and 2) activation of suicide genes, or color proteins for cancer cell detection (e.g., for complete surgical removal).  <br />Our system can be potentially designed according to unique characteristics of a patient's tumor, paving the way to personalized medicine. We hope that our strategy will change the approach to cancer treatments.</p>
          <p>
+
     
            Despite recent treatment advancements, cancer is still a major cause of mortality worldwide. One of the fundamental problems preventing the development of effective therapy is the difficulty to target cancer cells exclusively.
+
       
            <br />In Boomerang, we're engineering a genetic device based on a simple concept of AND logic gate: the activation of our CRISPR/Cas9-based system is dependent on the existence of two cancer-specific promoters that control the expression of Cas9 and gRNA, and the combination of these two will occur only in cancer cells. CRISPR/Cas9 system allows several applications of Boomerang: 1) disruption of genes essential for cancer survival; and 2) activation of suicide genes, or color proteins for cancer cell detection (e.g., for complete surgical removal).  <br />Our system can be potentially designed according to unique characteristics of a patient's tumor, paving the way to personalized medicine. We hope that our strategy will change the approach to cancer treatments.
+
        <br /><br />
          </p>
+
            <!-- movie -->
 
+
      <video width="900" controls>
 
+
              <source src="https://static.igem.org/mediawiki/2015/6/65/IGEMbgu.mp4" type="video/mp4">
          <br />
+
          <br />
+
          <!-- movie -->
+
          <video width="900" controls="">
+
            <source src="https://static.igem.org/mediawiki/2015/6/65/IGEMbgu.mp4" type="video/mp4">
+
 
               </video>
 
               </video>
          <!-- movie -->
+
</p>
 +
<!-- movie -->
  
          <br />
+
<br /><br />
          <br />
+
  
  
  
          <!-- SPONSERS -->
+
<!-- SPONSERS -->
 
         <!--
 
         <!--
 
<h2> <span class="mw-headline" id="Sponsors"> Sponsors </span></h2>
 
<h2> <span class="mw-headline" id="Sponsors"> Sponsors </span></h2>
Line 185: Line 141:
 
         <!-- Map of entering the website from around the world -->
 
         <!-- Map of entering the website from around the world -->
  
          <table>
+
  <table>
            <tr>
+
<tr>
              <td>
+
        <td style="border-style: hidden;"><div class="checklist" >
                <div class="checklist" >
+
          <div class="medal">
                  <div class="medal">
+
              <a href="https://2015.igem.org/Team:BGU_Israel/Achievements">
                    <a href="https://2015.igem.org/Team:BGU_Israel/Achievements">
+
                <img src="https://static.igem.org/mediawiki/2015/b/b7/Medalcheck.png" height="150px" width="600px" />
                      <img src="https://static.igem.org/mediawiki/2015/b/b7/Medalcheck.png" height="150px" width="600px" />
+
              </a>  
                    </a>
+
          </div></div></td>
                  </div>
+
        </tr></table>
                </div>
+
<br /><br />
              </td>
+
<!-- finish HERE ----------------------------------------------------------------------------------------------->
              <td>
+
                <center style="margin-top: 10px;">
+
                  <div id="clustrmaps-widget"></div>
+
                  <script type="text/javascript">  var _clustrmaps = { 'url': 'https://2015.igem.org/Team:BGU_Israel', 'user': 1176746, 'server': '3', 'id': 'clustrmaps-widget', 'version': 1, 'date': '2015-08-19', 'lang': 'en', 'corners': 'square' }; (function () { var s = document.createElement('script'); s.type = 'text/javascript'; s.async = true; s.src = 'http://www3.clustrmaps.com/counter/map.js'; var x = document.getElementsByTagName('script')[0]; x.parentNode.insertBefore(s, x); })();</script>
+
                  <noscript>
+
                    <a href="http://www3.clustrmaps.com/user/9bc11f4aa" target="blank">
+
                      <img src="http://www3.clustrmaps.com/stats/maps-no_clusters/2015.igem.org-Team-BGU_Israel-thumb.jpg" alt="Locations of visitors to this page" />
+
                    </a>
+
                  </noscript>
+
                </center>
+
              </td>
+
            </tr>
+
          </table>
+
 
+
  
 
               </div>
 
               </div>
Line 216: Line 158:
 
       </div>
 
       </div>
 
   <div class="visualClear"></div>
 
   <div class="visualClear"></div>
 
+
  <br /><br /><br /><br /><br /><br /><br /><br />
 
</html>
 
</html>
  
 
{{BGU_Israel/footer}}
 
{{BGU_Israel/footer}}

Latest revision as of 16:02, 18 September 2015

Team:BGU Israel



Achievements
Project description
Design
Results
Practices and Polices

The Boomerang system: synthetic machine for cancer therapy

Despite recent treatment advancements, cancer is still a major cause of mortality worldwide. One of the fundamental problems preventing the development of effective therapy is the difficulty to target cancer cells exclusively.
In Boomerang, we're engineering a genetic device based on a simple concept of AND logic gate: the activation of our CRISPR/Cas9-based system is dependent on the existence of two cancer-specific promoters that control the expression of Cas9 and gRNA, and the combination of these two will occur only in cancer cells. CRISPR/Cas9 system allows several applications of Boomerang: 1) disruption of genes essential for cancer survival; and 2) activation of suicide genes, or color proteins for cancer cell detection (e.g., for complete surgical removal).
Our system can be potentially designed according to unique characteristics of a patient's tumor, paving the way to personalized medicine. We hope that our strategy will change the approach to cancer treatments.